Sonnet BioTherapeutics Holdings Overview
Sonnet BioTherapeutics Holdings Discounted Cash Flow
DCF Analysis for SONN.
Get informed when a big investor buys or sells
+ FollowFair Value
$-0.42
Current Fair Value
$-0.42
↓ 133.4% Downside
Overvalued by 133.4% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison